Oncology Biosimilar Market Size is projected to reach USD 15.62 billion by 2031, growing at a CAGR…
New York, United States, Nov. 23, 2022 (GLOBE NEWSWIRE) -- A biosimilar is a generic version of a well-known biologic drug. Biologic drugs are medicines made from living things like cells, tissues, or proteins. A biosimilar drug is one…